Has the AMA announced new CPT codes for the AstraZeneca COVID-19 vaccine?

Yes. On December 17, 2020, the AMA announced the creation of 3 new CPT codes to report for the AstraZeneca COVID-19 vaccine, as well as its administration. However, it is important to point out that these codes are not yet effective. Per the AMA, the codes noted below will become effective only when the AstraZeneca COVID-19 vaccine product has been granted either full approval or an emergency use authorization (EUA) by the FDA. There is no timeline for when this may occur, however we will be sure to provide an update as soon as an announcement is made by the FDA. Below we have noted the new vaccine product and administration codes along with their long descriptions for your convenience.

AstraZeneca vaccine product code

91302: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, DNA, spike protein, chimpanzee adenovirus Oxford 1 (ChAdOx1) vector, preservative free, 5×1010 viral particles/0.5mL dosage, for intramuscular use

AstraZeneca administration codes

0021A: Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, DNA, spike protein, chimpanzee adenovirus Oxford 1 (ChAdOx1) vector, preservative free, 5×1010 viral particles/0.5mL dosage; first dose

0022A: Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, DNA, spike protein, chimpanzee adenovirus Oxford 1 (ChAdOx1) vector, preservative free, 5×1010 viral particles/0.5mL dosage; second dose

AMA press release, “AMA announces additional CPT codes for COVID-19 vaccines”:
https://www.ama-assn.org/press-center/press-releases/ama-announces-additional-cpt-codes-covid-19-vaccines